Melissa Stephenson – BioTuesdays

Developments

Think Research to acquire MDBriefCase Group

Think Research (TSXV:THNK) agreed to acquire closely-held MDBriefCase Group, a portfolio company of Persistence Capital Partners, for $25.3-million, mostly in stock. The transaction, which is expected to close in the...

January 20, 2021

Markets

Canaccord ups Neuronetics PT to $20 from $8

Canaccord Genuity raised its price target for Neuronetics (NASDAQ:STIM) to $20 from $8, reflecting the company’s strong fourth quarter preliminary financial results and a new focus on high-margin utilization, compared...

January 19, 2021

Developments

Sernova’s Cell Pouch shows sustained clinical benefit in Type 1 diabetes

Sernova (TSXV:SVA; OTC:SEOVF; FSE:PSH) reported additional positive preliminary safety and efficacy data for its Cell Pouch transplanted with insulin producing cells in patients with Type 1 diabetes. Data presented at...

January 15, 2021

Executive Moves

Justin Zelin joins BTIG as biotech analyst

BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology, immunology and...

January 15, 2021

Executive Moves

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary. Mr. Kenny has been with...

January 13, 2021

Developments

Diabeloop, SFC Fluidics in U.S. development pact for Type 1 diabetes

Diabeloop and SFC Fluidics agreed to develop a Type 1 diabetes system that integrates SFC’s alternate controller-enabled (ACE) insulin pod into Diabeloop’s automated insulin delivery solution in the U.S. The new...

January 11, 2021

Developments

iBio’s FastPharming featured in Genetic Engineering & Biotechnology News

iBio’s (NYSE American:IBIO) plant-based FastPharming System and customized FastGlycaneering tools were featured in an article in Genetic Engineering & Biotechnology. Sylvain Marcel, Ph.D., VP of protein expression...

January 11, 2021

Developments

Soricimed Biopharma, Orano Med in radiotherapeutics pact to treat solid tumors

Closely-held Soricimed Biopharma and Orano Med, a nuclear biotech company based in Piano, TX entered an agreement to develop a novel peptide receptor radionuclide therapy (PRRT) to treat solid tumor cancers. The...

January 7, 2021

Developments

IntelGenx receives first purchase order for CBD filmstrips from Heritage Cannabis

IntelGenx (TSXV:IGX; OTCQB:IGXT) executed of a definitive supply agreement with Heritage Cannabis Holdings (CSE:CANN; OTCQX:HERTF) to manufacture and supply filmstrip products containing 10 mg of cannabidiol (CBD) using...

January 7, 2021

Developments

Profound Medical Q4 preliminary revenue beats consensus estimates

Profound Medical (NASDAQ:PROF; TSX:PRN) preliminary revenue for the fourth quarter of 2020 of $3.7-million beat the Street estimate of $2.7-million, despite the pandemic surge. “We believe strong TULSA-PRO adoption and...

January 6, 2021

Author - Melissa Stephenson

Think Research to acquire MDBriefCase Group

Canaccord ups Neuronetics PT to $20 from $8

Sernova’s Cell Pouch shows sustained clinical benefit in Type 1 diabetes

Justin Zelin joins BTIG as biotech analyst

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Diabeloop, SFC Fluidics in U.S. development pact for Type 1 diabetes

iBio’s FastPharming featured in Genetic Engineering & Biotechnology News

Soricimed Biopharma, Orano Med in radiotherapeutics pact to treat solid tumors

IntelGenx receives first purchase order for CBD filmstrips from Heritage Cannabis

Profound Medical Q4 preliminary revenue beats consensus estimates

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter